Showing results (81-90 of 1,102) with videos related to
Sort By:
Pageof 111
Pediatric Nephrology (Berlin, Germany)|July 17, 2004
Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much?J H M Beimler, K AndrassyThrombosis Research|January 15, 1994
Neutralization of the anticoagulant activity of low molecular weight heparin LU 47311 (Clivarin) in man by protamine chlorideK Andrassy, V Eschenfelder, E WeberLaryngo- Rhino- Otologie|April 29, 1998
[Macrolide antibiotic-induced vasculitis (Churg-Strauss syndrome)]A Dietz, C Hübner, K AndrassyExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitusM Zumbach, M Hofmann, V Borcea, et al.Thrombosis and Haemostasis|June 1, 1996
Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitisO Hergesell, K Andrassy, P NawrothAdvances in Experimental Medicine and Biology|January 1, 1993
p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvementC Dringenberg, S Apenberg, K AndrassyAmerican Heart Journal|May 1, 1993
Hypertension in diabetic nephropathy: prevention and treatmentE RitzExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Nephropathy in type II diabetesE RitzPageof 111